TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	0.00164694401965966	-6.40883381764196	37	2	0.222222222222222	9	5314	7039,3486	TGFA,IGFBP3	TGFA,IGFBP3
WP615	Senescence and Autophagy in Cancer	0.0129502779878942	-4.34663802482033	106	2	0.222222222222222	9	5314	3486,7057	IGFBP3,THBS1	IGFBP3,THBS1
WP322	Osteoblast Signaling	0.0234801051129948	-3.7516018073289	14	1	0.111111111111111	9	5314	4982	TNFRSF11B	TNFRSF11B
WP12	Osteoclast Signaling	0.0267940842969838	-3.6195741510181	16	1	0.111111111111111	9	5314	4982	TNFRSF11B	TNFRSF11B
WP289	Myometrial Relaxation and Contraction Pathways	0.0275689848306457	-3.5910638761461	158	2	0.222222222222222	9	5314	3489,3486	IGFBP6,IGFBP3	IGFBP6,IGFBP3
WP2377	Integrated Pancreatic Cancer Pathway	0.0414601470887115	-3.183022624255	197	2	0.222222222222222	9	5314	3486,7057	IGFBP3,THBS1	IGFBP3,THBS1
WP2870	Extracellular vesicle-mediated signaling in recipient cells	0.0497133945561208	-3.00148087401891	30	1	0.111111111111111	9	5314	7039	TGFA	TGFA
WP727	Monoamine Transport	0.0529481045869756	-2.93844300385539	32	1	0.111111111111111	9	5314	4982	TNFRSF11B	TNFRSF11B
WP2828	Bladder Cancer	0.0529481045869756	-2.93844300385539	32	1	0.111111111111111	9	5314	7057	THBS1	THBS1
WP453	Inflammatory Response Pathway	0.0545617863469402	-2.90842152501992	33	1	0.111111111111111	9	5314	7057	THBS1	THBS1
WP455	GPCRs, Class A Rhodopsin-like	0.0679248607270115	-2.68935317406548	259	2	0.222222222222222	9	5314	2861,53836	GPR37,GPR87	GPR37,GPR87
WP2911	miRNA targets in ECM and membrane receptors	0.0705646894584864	-2.65122540891255	43	1	0.111111111111111	9	5314	7057	THBS1	THBS1
WP410	Diurnally Regulated Genes with Circadian Orthologs	0.0800504362550953	-2.52509838977169	49	1	0.111111111111111	9	5314	11030	RBPMS	RBPMS
WP673	ErbB Signaling Pathway	0.0878893856678923	-2.43167623621392	54	1	0.111111111111111	9	5314	7039	TGFA	TGFA
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	0.0878893856678923	-2.43167623621392	54	1	0.111111111111111	9	5314	7057	THBS1	THBS1
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	0.0894500312061374	-2.41407512016065	55	1	0.111111111111111	9	5314	4982	TNFRSF11B	TNFRSF11B
WP560	TGF-beta Receptor Signaling	0.0941177361176783	-2.3632087685606	58	1	0.111111111111111	9	5314	7057	THBS1	THBS1
WP3624	Lung fibrosis	0.10184999450296	-2.28425419028124	63	1	0.111111111111111	9	5314	7039	TGFA	TGFA
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	0.109523530888509	-2.21161585885299	68	1	0.111111111111111	9	5314	7039	TGFA	TGFA
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.112576590848099	-2.18412148144332	70	1	0.111111111111111	9	5314	2861	GPR37	GPR37
WP2371	Parkinsons Disease Pathway	0.132195702771516	-2.02347185760334	83	1	0.111111111111111	9	5314	2861	GPR37	GPR37
WP1772	Apoptosis Modulation and Signaling	0.148494342171204	-1.90720842132241	94	1	0.111111111111111	9	5314	4982	TNFRSF11B	TNFRSF11B
WP366	TGF-beta Signaling Pathway	0.204110507565471	-1.58909372805412	133	1	0.111111111111111	9	5314	7057	THBS1	THBS1
WP2884	NRF2 pathway	0.217840295235118	-1.52399307533332	143	1	0.111111111111111	9	5314	7039	TGFA	TGFA
WP2858	Ectoderm Differentiation	0.217840295235118	-1.52399307533332	143	1	0.111111111111111	9	5314	4982	TNFRSF11B	TNFRSF11B
WP536	Calcium Regulation in the Cardiac Cell	0.228672112430909	-1.47546612491242	151	1	0.111111111111111	9	5314	481	ATP1B1	ATP1B1
WP306	Focal Adhesion	0.285898382484332	-1.25211883729726	195	1	0.111111111111111	9	5314	7057	THBS1	THBS1
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	0.999999999975777	-2.42233035362715e-11	74	0	0	9	5314
WP24	Peptide GPCRs	0.999999999975777	-2.42233035362715e-11	74	0	0	9	5314
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	0.999999999982505	-1.74950369113152e-11	73	0	0	9	5314
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	0.999999999983371	-1.66295174427955e-11	12	0	0	9	5314
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	0.999999999983371	-1.66295174427955e-11	12	0	0	9	5314
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	0.999999999983371	-1.66295174427955e-11	12	0	0	9	5314
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	0.999999999983371	-1.66295174427955e-11	12	0	0	9	5314
WP106	Alanine and aspartate metabolism	0.999999999983371	-1.66295174427955e-11	12	0	0	9	5314
WP2007	Iron metabolism in placenta	0.999999999983371	-1.66295174427955e-11	12	0	0	9	5314
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	0.999999999983371	-1.66295174427955e-11	12	0	0	9	5314
WP2290	RalA downstream regulated genes	0.999999999983371	-1.66295174427955e-11	12	0	0	9	5314
WP34	Ovarian Infertility Genes	0.999999999984366	-1.56340881295616e-11	32	0	0	9	5314
WP3893	Development and heterogeneity of the ILC family	0.999999999984366	-1.56340881295616e-11	32	0	0	9	5314
WP2525	Trans-sulfuration and one carbon metabolism	0.999999999984366	-1.56340881295616e-11	32	0	0	9	5314
WP3858	Toll-like Receptor Signaling	0.999999999984366	-1.56340881295616e-11	32	0	0	9	5314
WP2875	Constitutive Androstane Receptor Pathway	0.999999999984366	-1.56340881295616e-11	32	0	0	9	5314
WP3594	Circadian rythm related genes	0.999999999985305	-1.46946697013764e-11	207	0	0	9	5314
WP231	TNF alpha Signaling Pathway	0.999999999985678	-1.4322109386002e-11	94	0	0	9	5314
WP2795	Cardiac Hypertrophic Response	0.999999999986251	-1.37490128558244e-11	57	0	0	9	5314
WP195	IL-1 signaling pathway	0.999999999986251	-1.37490128558244e-11	57	0	0	9	5314
WP3892	Development of pulmonary dendritic cells and macrophage subsets	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP3871	Valproic acid pathway	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP186	Homologous recombination	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP1434	Osteopontin Signaling	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP1423	Ganglio Sphingolipid Metabolism	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP2881	Estrogen Receptor Pathway	0.999999999986255	-1.37454950365112e-11	13	0	0	9	5314
WP2857	Mesodermal Commitment Pathway	0.999999999986275	-1.37253656465382e-11	156	0	0	9	5314
WP694	Arylamine metabolism	0.999999999986297	-1.37031369545318e-11	6	0	0	9	5314
WP1981	Thyroxine (Thyroid Hormone) Production	0.999999999986297	-1.37031369545318e-11	6	0	0	9	5314
WP1600	Nicotine Metabolism	0.999999999986297	-1.37031369545318e-11	6	0	0	9	5314
WP3891	Benzene metabolism	0.999999999986297	-1.37031369545318e-11	6	0	0	9	5314
WP117	GPCRs, Other	0.999999999986381	-1.3618985743073e-11	95	0	0	9	5314
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	0.999999999986491	-1.3509010930451e-11	17	0	0	9	5314
WP2289	Drug Induction of Bile Acid Pathway	0.999999999986491	-1.3509010930451e-11	17	0	0	9	5314
WP554	ACE Inhibitor Pathway	0.999999999986491	-1.3509010930451e-11	17	0	0	9	5314
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	0.999999999986491	-1.3509010930451e-11	17	0	0	9	5314
WP78	TCA Cycle	0.999999999986491	-1.3509010930451e-11	17	0	0	9	5314
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	0.999999999986491	-1.3509010930451e-11	17	0	0	9	5314
WP3874	Canonical and Non-Canonical TGF-B signaling	0.999999999986491	-1.3509010930451e-11	17	0	0	9	5314
WP2249	Metastatic brain tumor	0.999999999987067	-1.29325658544005e-11	28	0	0	9	5314
WP2361	Gastric Cancer Network 1	0.999999999987067	-1.29325658544005e-11	28	0	0	9	5314
WP623	Oxidative phosphorylation	0.999999999987465	-1.25350252746546e-11	54	0	0	9	5314
WP3286	Copper homeostasis	0.999999999987465	-1.25350252746546e-11	54	0	0	9	5314
WP466	DNA Replication	0.999999999987627	-1.23725989336913e-11	42	0	0	9	5314
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	0.999999999987627	-1.23725989336913e-11	42	0	0	9	5314
WP405	Eukaryotic Transcription Initiation	0.999999999987627	-1.23725989336913e-11	42	0	0	9	5314
WP49	IL-2 Signaling Pathway	0.999999999987627	-1.23725989336913e-11	42	0	0	9	5314
WP2636	Common Pathways Underlying Drug Addiction	0.999999999987627	-1.23725989336913e-11	42	0	0	9	5314
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.999999999987765	-1.22349595594018e-11	144	0	0	9	5314
WP561	Heme Biosynthesis	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP3297	EV release from cardiac cells and their functional effects	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP3875	ATR Signaling	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP3300	Dual hijack model of Vif in HIV infection	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP696	Benzo(a)pyrene metabolism	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP288	NLR Proteins	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP531	Mismatch repair	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP3674	Tgif disruption of Shh signaling	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP3585	Cytosine methylation	0.999999999987812	-1.21879144596836e-11	9	0	0	9	5314
WP127	IL-5 Signaling Pathway	0.999999999988171	-1.18285562206431e-11	40	0	0	9	5314
WP2516	ATM Signaling Pathway	0.999999999988171	-1.18285562206431e-11	40	0	0	9	5314
WP524	G13 Signaling Pathway	0.999999999988171	-1.18285562206431e-11	40	0	0	9	5314
WP2855	Dopaminergic Neurogenesis	0.99999999998875	-1.12500245671176e-11	30	0	0	9	5314
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	0.99999999998875	-1.12500245671176e-11	30	0	0	9	5314
WP241	One Carbon Metabolism	0.99999999998875	-1.12500245671176e-11	30	0	0	9	5314
WP3851	TLR4 Signaling and Tolerance	0.99999999998875	-1.12500245671176e-11	30	0	0	9	5314
WP129	Matrix Metalloproteinases	0.99999999998875	-1.12500245671176e-11	30	0	0	9	5314
WP98	Prostaglandin Synthesis and Regulation	0.99999999998875	-1.12500245671176e-11	30	0	0	9	5314
WP2596	Gastric acid production	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP1310	Selenium Micronutrient Network	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP1272	Selenium Micronutrient Network	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP134	Pentose Phosphate Pathway	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP528	Acetylcholine Synthesis	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP699	Aflatoxin B1 metabolism	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP3924	Hfe effect on hepcidin production	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP2805	RNA interference	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP438	Non-homologous end joining	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP3595	mir-124 predicted interactions with cell cycle and differentiation	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP1995	Effects of Nitric Oxide	0.99999999998881	-1.11900199003947e-11	7	0	0	9	5314
WP411	mRNA Processing	0.999999999988815	-1.11847623242033e-11	132	0	0	9	5314
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	0.999999999988815	-1.11847623242033e-11	132	0	0	9	5314
WP702	Metapathway biotransformation	0.999999999988971	-1.10286326115305e-11	178	0	0	9	5314
WP382	MAPK Signaling Pathway	0.999999999988981	-1.10192776887573e-11	170	0	0	9	5314
WP3646	Hepatitis C and Hepatocellular Carcinoma	0.999999999989504	-1.04962852386447e-11	51	0	0	9	5314
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	0.999999999989504	-1.04962852386447e-11	51	0	0	9	5314
WP2431	Spinal Cord Injury	0.999999999989581	-1.04192982982144e-11	119	0	0	9	5314
WP534	Glycolysis and Gluconeogenesis	0.999999999989945	-1.00548049698198e-11	49	0	0	9	5314
WP286	IL-3 Signaling Pathway	0.999999999989945	-1.00548049698198e-11	49	0	0	9	5314
WP179	Cell Cycle	0.999999999989946	-1.00539407663541e-11	105	0	0	9	5314
WP3865	RIG-I-like Receptor Signaling	0.99999999999012	-9.87981376973836e-12	61	0	0	9	5314
WP2328	Allograft Rejection	0.999999999990137	-9.86280542286527e-12	80	0	0	9	5314
WP1971	Integrated Cancer Pathway	0.9999999999903	-9.70043779014079e-12	46	0	0	9	5314
WP28	Selenium Metabolism and Selenoproteins	0.9999999999903	-9.70043779014079e-12	46	0	0	9	5314
WP465	Tryptophan metabolism	0.9999999999903	-9.70043779014079e-12	46	0	0	9	5314
WP268	Notch Signaling Pathway	0.9999999999903	-9.70043779014079e-12	46	0	0	9	5314
WP1591	Heart Development	0.9999999999903	-9.70043779014079e-12	46	0	0	9	5314
WP3878	ATM Signaling Network in Development and Disease	0.9999999999903	-9.70043779014079e-12	46	0	0	9	5314
WP2526	PDGF Pathway	0.999999999990373	-9.6268482144102e-12	38	0	0	9	5314
WP2447	Amyotrophic lateral sclerosis (ALS)	0.999999999990373	-9.6268482144102e-12	38	0	0	9	5314
WP383	Striated Muscle Contraction	0.999999999990373	-9.6268482144102e-12	38	0	0	9	5314
WP2029	Cell Differentiation - Index	0.999999999990373	-9.6268482144102e-12	38	0	0	9	5314
WP428	Wnt Signaling Pathway	0.999999999990752	-9.2477254387603e-12	70	0	0	9	5314
WP1984	Integrated Breast Cancer Pathway	0.999999999990761	-9.23926198405347e-12	154	0	0	9	5314
WP698	Glucuronidation	0.999999999990789	-9.21051808646118e-12	26	0	0	9	5314
WP325	Triacylglyceride Synthesis	0.999999999990789	-9.21051808646118e-12	26	0	0	9	5314
WP581	EPO Receptor Signaling	0.999999999990789	-9.21051808646118e-12	26	0	0	9	5314
WP530	Cytokines and Inflammatory Response	0.999999999990789	-9.21051808646118e-12	26	0	0	9	5314
WP2878	PPAR Alpha Pathway	0.999999999990789	-9.21051808646118e-12	26	0	0	9	5314
WP26	Signal Transduction of S1P Receptor	0.999999999990789	-9.21051808646118e-12	26	0	0	9	5314
WP2853	Endoderm Differentiation	0.999999999991028	-8.97221048407518e-12	145	0	0	9	5314
WP1449	Regulation of toll-like receptor signaling pathway	0.999999999991028	-8.97221048407518e-12	145	0	0	9	5314
WP2509	Nanoparticle triggered autophagic cell death	0.999999999991134	-8.86565124681155e-12	24	0	0	9	5314
WP262	EBV LMP1 signaling	0.999999999991134	-8.86565124681155e-12	24	0	0	9	5314
WP334	GPCRs, Class B Secretin-like	0.999999999991134	-8.86565124681155e-12	24	0	0	9	5314
WP1539	Angiogenesis	0.999999999991134	-8.86565124681155e-12	24	0	0	9	5314
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	0.999999999991134	-8.86565124681155e-12	24	0	0	9	5314
WP138	Androgen receptor signaling pathway	0.999999999991181	-8.81860562068076e-12	90	0	0	9	5314
WP477	Cytoplasmic Ribosomal Proteins	0.999999999991181	-8.81860562068076e-12	90	0	0	9	5314
WP80	Nucleotide GPCRs	0.999999999991758	-8.2418197525143e-12	11	0	0	9	5314
WP2854	Gene regulatory network modelling somitogenesis	0.999999999991758	-8.2418197525143e-12	11	0	0	9	5314
WP3630	NAD metabolism, sirtuins and aging	0.999999999991758	-8.2418197525143e-12	11	0	0	9	5314
WP1455	Serotonin Transporter Activity	0.999999999991758	-8.2418197525143e-12	11	0	0	9	5314
WP2513	Nanoparticle triggered regulated necrosis	0.999999999991758	-8.2418197525143e-12	11	0	0	9	5314
WP3303	Rac1/Pak1/p38/MMP-2 pathway	0.999999999991858	-8.14235861608207e-12	68	0	0	9	5314
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	0.999999999991858	-8.14235861608207e-12	68	0	0	9	5314
WP45	G1 to S cell cycle control	0.999999999991858	-8.14235861608207e-12	68	0	0	9	5314
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	0.999999999991858	-8.14235861608207e-12	68	0	0	9	5314
WP23	B Cell Receptor Signaling Pathway	0.999999999991955	-8.04503427652658e-12	98	0	0	9	5314
WP1438	Influenza A virus infection	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP2816	Felbamate Metabolism	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP1273	Folic Acid Network	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP1311	Folic Acid Network	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP2646	Lidocaine metabolism	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP2866	mir34a and TGIF2 in osteoclastogenesis	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP2943	Hypoxia-mediated EMT and Stemness	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP2366	Butyrate-induced histone acetylation	0.999999999992037	-7.96301964627467e-12	2	0	0	9	5314
WP400	p38 MAPK Signaling Pathway	0.999999999992076	-7.92441566041726e-12	34	0	0	9	5314
WP143	Fatty Acid Beta Oxidation	0.999999999992076	-7.92441566041726e-12	34	0	0	9	5314
WP1601	Fluoropyrimidine Activity	0.999999999992076	-7.92441566041726e-12	34	0	0	9	5314
WP313	Signaling of Hepatocyte Growth Factor Receptor	0.999999999992076	-7.92441566041726e-12	34	0	0	9	5314
WP3601	Composition of Lipid Particles	0.99999999999226	-7.73974941929401e-12	10	0	0	9	5314
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	0.99999999999226	-7.73974941929401e-12	10	0	0	9	5314
WP2874	Liver X Receptor Pathway	0.99999999999226	-7.73974941929401e-12	10	0	0	9	5314
WP2333	Trans-sulfuration pathway	0.99999999999226	-7.73974941929401e-12	10	0	0	9	5314
WP704	Methylation Pathways	0.99999999999226	-7.73974941929401e-12	10	0	0	9	5314
WP2113	Type III interferon signaling	0.99999999999226	-7.73974941929401e-12	10	0	0	9	5314
WP496	Steroid Biosynthesis	0.99999999999226	-7.73974941929401e-12	10	0	0	9	5314
WP1531	Vitamin D Metabolism	0.99999999999226	-7.73974941929401e-12	10	0	0	9	5314
WP2873	Aryl Hydrocarbon Receptor Pathway	0.999999999992308	-7.69167988627026e-12	48	0	0	9	5314
WP2848	Differentiation Pathway	0.999999999992308	-7.69167988627026e-12	48	0	0	9	5314
WP2849	Hematopoietic Stem Cell Differentiation	0.999999999992308	-7.69167988627026e-12	48	0	0	9	5314
WP2586	Aryl Hydrocarbon Receptor	0.999999999992308	-7.69167988627026e-12	48	0	0	9	5314
WP710	DNA Damage Response (only ATM dependent)	0.999999999992426	-7.57452883354588e-12	114	0	0	9	5314
WP2332	Interleukin-11 Signaling Pathway	0.999999999992461	-7.53859600882828e-12	44	0	0	9	5314
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	0.999999999992461	-7.53859600882828e-12	44	0	0	9	5314
WP716	Vitamin A and Carotenoid Metabolism	0.999999999992461	-7.53859600882828e-12	44	0	0	9	5314
WP712	Estrogen signaling pathway	0.999999999992476	-7.52377163117214e-12	23	0	0	9	5314
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	0.999999999992476	-7.52377163117214e-12	23	0	0	9	5314
WP2355	Corticotropin-releasing hormone signaling pathway	0.999999999992488	-7.51154311901784e-12	93	0	0	9	5314
WP1530	miRNA Regulation of DNA Damage Response	0.999999999992488	-7.51154311901784e-12	93	0	0	9	5314
WP111	Electron Transport Chain	0.999999999992488	-7.51154311901784e-12	93	0	0	9	5314
WP43	Oxidation by Cytochrome P450	0.9999999999933	-6.69995976092631e-12	63	0	0	9	5314
WP550	Biogenic Amine Synthesis	0.999999999993377	-6.62311436089298e-12	16	0	0	9	5314
WP1946	Cori Cycle	0.999999999993377	-6.62311436089298e-12	16	0	0	9	5314
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	0.999999999993377	-6.62311436089298e-12	16	0	0	9	5314
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	0.999999999993377	-6.62311436089298e-12	16	0	0	9	5314
WP3644	NAD+ metabolism	0.999999999993377	-6.62311436089298e-12	16	0	0	9	5314
WP47	Hedgehog Signaling Pathway	0.999999999993377	-6.62311436089298e-12	16	0	0	9	5314
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	0.999999999993377	-6.62311436089298e-12	16	0	0	9	5314
WP53	ID signaling pathway	0.999999999993377	-6.62311436089298e-12	16	0	0	9	5314
WP707	DNA Damage Response	0.999999999993423	-6.57657357503393e-12	69	0	0	9	5314
WP176	Folate Metabolism	0.999999999993423	-6.57657357503393e-12	69	0	0	9	5314
WP2369	Histone Modifications	0.999999999993423	-6.57657357503393e-12	69	0	0	9	5314
WP3617	Photodynamic therapy-induced NF-kB survival signaling	0.999999999993497	-6.50306348088774e-12	35	0	0	9	5314
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	0.999999999993497	-6.50306348088774e-12	35	0	0	9	5314
WP244	Alpha 6 Beta 4 signaling pathway	0.999999999993497	-6.50306348088774e-12	35	0	0	9	5314
WP254	Apoptosis	0.999999999993726	-6.27424795819751e-12	86	0	0	9	5314
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	0.999999999993796	-6.20391405304494e-12	18	0	0	9	5314
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	0.999999999993796	-6.20391405304494e-12	18	0	0	9	5314
WP3413	NOTCH1 regulation of human endothelial cell calcification	0.999999999993796	-6.20391405304494e-12	18	0	0	9	5314
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	0.999999999993796	-6.20391405304494e-12	18	0	0	9	5314
WP692	Sulfation Biotransformation Reaction	0.999999999993796	-6.20391405304494e-12	18	0	0	9	5314
WP3298	Melatonin metabolism and effects	0.999999999993814	-6.18613483500401e-12	36	0	0	9	5314
WP2012	miRs in Muscle Cell Differentiation	0.999999999993814	-6.18613483500401e-12	36	0	0	9	5314
WP500	Glycogen Metabolism	0.999999999993814	-6.18613483500401e-12	36	0	0	9	5314
WP61	Notch Signaling Pathway	0.999999999994071	-5.92870877263522e-12	62	0	0	9	5314
WP3584	MECP2 and Associated Rett Syndrome	0.999999999994071	-5.92870877263522e-12	62	0	0	9	5314
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	0.999999999994071	-5.92870877263522e-12	62	0	0	9	5314
WP558	Complement and Coagulation Cascades	0.999999999994166	-5.83444014550821e-12	60	0	0	9	5314
WP3527	Preimplantation Embryo	0.999999999994166	-5.83444014550821e-12	60	0	0	9	5314
WP304	Kit receptor signaling pathway	0.999999999994166	-5.83444014550821e-12	60	0	0	9	5314
WP399	Wnt Signaling Pathway and Pluripotency	0.999999999994555	-5.44504068217844e-12	106	0	0	9	5314
WP1544	MicroRNAs in cardiomyocyte hypertrophy	0.999999999994902	-5.09761058790471e-12	102	0	0	9	5314
WP2064	Neural Crest Differentiation	0.999999999994902	-5.09761058790471e-12	102	0	0	9	5314
WP51	Regulation of Actin Cytoskeleton	0.999999999994976	-5.0240678573486e-12	149	0	0	9	5314
WP516	Hypertrophy Model	0.999999999995066	-4.93403852556374e-12	20	0	0	9	5314
WP1742	TP53 Network	0.999999999995066	-4.93403852556374e-12	20	0	0	9	5314
WP1422	Sphingolipid Metabolism	0.999999999995066	-4.93403852556374e-12	20	0	0	9	5314
WP391	Mitochondrial Gene Expression	0.999999999995066	-4.93403852556374e-12	20	0	0	9	5314
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	0.999999999995066	-4.93403852556374e-12	20	0	0	9	5314
WP497	Urea cycle and metabolism of amino groups	0.999999999995066	-4.93403852556374e-12	20	0	0	9	5314
WP2261	Signaling Pathways in Glioblastoma	0.999999999995334	-4.6655972737825e-12	83	0	0	9	5314
WP3845	Canonical  and Non-canonical Notch signaling	0.999999999995367	-4.63333749343047e-12	27	0	0	9	5314
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	0.999999999995367	-4.63333749343047e-12	27	0	0	9	5314
WP2112	IL17 signaling pathway	0.999999999995387	-4.61334052576064e-12	31	0	0	9	5314
WP408	Oxidative Stress	0.999999999995387	-4.61334052576064e-12	31	0	0	9	5314
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	0.999999999995387	-4.61334052576064e-12	31	0	0	9	5314
WP15	Selenium Micronutrient Network	0.999999999995559	-4.4413981704875e-12	87	0	0	9	5314
WP2190	One carbon donor	0.999999999995613	-4.38689796294911e-12	1	0	0	9	5314
WP1	Statin Pathway	0.999999999995613	-4.38689796294911e-12	1	0	0	9	5314
WP188	Focal Adhesion	0.999999999995613	-4.38689796294911e-12	1	0	0	9	5314
WP3191	TSLP Signaling Pathway	0.999999999995613	-4.38689796294911e-12	1	0	0	9	5314
WP3627	Gut-Liver Indole Metabolism	0.999999999995613	-4.38689796294911e-12	1	0	0	9	5314
WP108	Selenium metabolism/Selenoproteins	0.999999999995613	-4.38689796294911e-12	1	0	0	9	5314
WP661	Glucose Homeostasis	0.999999999995613	-4.38689796294911e-12	1	0	0	9	5314
WP2536	Colchicine Metabolic Pathway	0.999999999995613	-4.38689796294911e-12	1	0	0	9	5314
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	0.999999999995817	-4.18271800662928e-12	25	0	0	9	5314
WP1528	Physiological and Pathological Hypertrophy  of the Heart	0.999999999995817	-4.18271800662928e-12	25	0	0	9	5314
WP2895	Differentiation of white and brown adipocyte	0.999999999995817	-4.18271800662928e-12	25	0	0	9	5314
WP2865	IL1 and megakaryocytes in obesity	0.999999999995817	-4.18271800662928e-12	25	0	0	9	5314
WP205	IL-7 Signaling Pathway	0.999999999995817	-4.18271800662928e-12	25	0	0	9	5314
WP35	G Protein Signaling Pathways	0.999999999995915	-4.08506385672262e-12	96	0	0	9	5314
WP2272	Pathogenic Escherichia coli infection	0.999999999995945	-4.05538104421054e-12	55	0	0	9	5314
WP395	IL-4 Signaling Pathway	0.999999999995945	-4.05538104421054e-12	55	0	0	9	5314
WP585	Interferon type I signaling pathways	0.999999999995945	-4.05538104421054e-12	55	0	0	9	5314
WP2491	Diclofenac Metabolic Pathway	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP2889	Oxytocin signaling	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP3633	Caffeine and Theobromine metabolism	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP690	Polyol Pathway	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP733	Serotonin Receptor 2 and STAT3 Signaling	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP897	Androgen receptor signaling pathway	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP521	Amino acid conjugation of benzoic acid	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP2253	Pilocytic astrocytoma	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP1603	Nicotine Activity on Chromaffin Cells	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP1133	Androgen receptor signaling pathway	0.999999999996198	-3.80214435110994e-12	4	0	0	9	5314
WP2637	Structural Pathway of Interleukin 1 (IL-1)	0.999999999996966	-3.03401535737205e-12	50	0	0	9	5314
WP1545	miRNAs involved in DNA damage response	0.999999999996966	-3.03401535737205e-12	50	0	0	9	5314
WP2034	Leptin signaling pathway	0.999999999997168	-2.83179515446078e-12	76	0	0	9	5314
WP2037	Prolactin Signaling Pathway	0.999999999997168	-2.83179515446078e-12	76	0	0	9	5314
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	0.999999999997168	-2.83179515446078e-12	76	0	0	9	5314
WP3596	miR-517 relationship with ARCN1 and USP1	0.999999999997303	-2.69664467672352e-12	5	0	0	9	5314
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	0.999999999997303	-2.69664467672352e-12	5	0	0	9	5314
WP311	Synthesis and Degradation of Ketone Bodies	0.999999999997303	-2.69664467672352e-12	5	0	0	9	5314
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	0.999999999997303	-2.69664467672352e-12	5	0	0	9	5314
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	0.999999999997303	-2.69664467672352e-12	5	0	0	9	5314
WP2542	Sulindac Metabolic Pathway	0.999999999997303	-2.69664467672352e-12	5	0	0	9	5314
WP2267	Synaptic Vesicle Pathway	0.999999999997335	-2.66479164229943e-12	52	0	0	9	5314
WP3529	Zinc homeostasis	0.999999999997405	-2.59474590420202e-12	37	0	0	9	5314
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	0.999999999997405	-2.59474590420202e-12	37	0	0	9	5314
WP619	Type II interferon signaling (IFNG)	0.999999999997405	-2.59474590420202e-12	37	0	0	9	5314
WP1471	Target Of Rapamycin (TOR) Signaling	0.999999999997405	-2.59474590420202e-12	37	0	0	9	5314
WP229	Irinotecan Pathway	0.999999999997664	-2.33643283411793e-12	14	0	0	9	5314
WP3853	ERK Pathway in Huntington's Disease	0.999999999997664	-2.33643283411793e-12	14	0	0	9	5314
WP2436	Dopamine metabolism	0.999999999997664	-2.33643283411793e-12	14	0	0	9	5314
WP2446	Retinoblastoma (RB) in Cancer	0.999999999997776	-2.22438114933516e-12	88	0	0	9	5314
WP481	Insulin Signaling	0.999999999997938	-2.06207433820882e-12	161	0	0	9	5314
WP364	IL-6 signaling pathway	0.999999999998376	-1.62398427501376e-12	43	0	0	9	5314
WP437	EGF/EGFR Signaling Pathway	0.999999999998377	-1.62308521937135e-12	162	0	0	9	5314
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	0.999999999998377	-1.62308521937135e-12	162	0	0	9	5314
WP107	Translation Factors	0.99999999999883	-1.17029862033893e-12	53	0	0	9	5314
WP1533	Vitamin B12 Metabolism	0.99999999999883	-1.17029862033893e-12	53	0	0	9	5314
WP2406	Cardiac Progenitor Differentiation	0.99999999999883	-1.17029862033893e-12	53	0	0	9	5314
WP363	Wnt Signaling Pathway Netpath	0.99999999999883	-1.17029862033893e-12	53	0	0	9	5314
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	0.999999999999239	-7.61216372503781e-13	41	0	0	9	5314
WP170	Nuclear Receptors	0.999999999999246	-7.53544321277594e-13	39	0	0	9	5314
WP2583	T-Cell Receptor and Co-stimulatory Signaling	0.999999999999319	-6.81317471127094e-13	29	0	0	9	5314
WP422	MAPK Cascade	0.999999999999319	-6.81317471127094e-13	29	0	0	9	5314
WP3613	Photodynamic therapy-induced unfolded protein response	0.999999999999319	-6.81317471127094e-13	29	0	0	9	5314
WP2643	Nanoparticle-mediated activation of receptor signaling	0.999999999999319	-6.81317471127094e-13	29	0	0	9	5314
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	0.999999999999354	-6.46305336498378e-13	47	0	0	9	5314
WP1602	Nicotine Activity on Dopaminergic Neurons	0.99999999999942	-5.80250571987974e-13	21	0	0	9	5314
WP2533	Glycerophospholipid Biosynthetic Pathway	0.99999999999942	-5.80250571987974e-13	21	0	0	9	5314
WP691	Tamoxifen metabolism	0.99999999999942	-5.80250571987974e-13	21	0	0	9	5314
WP2507	Nanomaterial induced apoptosis	0.99999999999942	-5.80250571987974e-13	21	0	0	9	5314
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	0.99999999999942	-5.80250571987974e-13	21	0	0	9	5314
WP3408	Evolocumab Mechanism	1.00000000000061	6.05859868086018e-13	3	0	0	9	5314
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	1.00000000000061	6.05859868086018e-13	3	0	0	9	5314
WP236	Adipogenesis	1.00000000000084	8.41246416035476e-13	131	0	0	9	5314
WP2363	Gastric Cancer Network 2	1.00000000000116	1.16191027371104e-12	33	0	0	9	5314
WP3676	BDNF-TrkB Signaling	1.00000000000116	1.16191027371104e-12	33	0	0	9	5314
WP2197	Endothelin Pathways	1.00000000000116	1.16191027371104e-12	33	0	0	9	5314
WP430	Statin Pathway	1.00000000000116	1.16191027371104e-12	33	0	0	9	5314
WP58	Monoamine GPCRs	1.00000000000116	1.16191027371104e-12	33	0	0	9	5314
WP75	Toll-like Receptor Signaling Pathway	1.00000000000197	1.97408537326969e-12	103	0	0	9	5314
WP185	Integrin-mediated Cell Adhesion	1.00000000000197	1.97408537326969e-12	103	0	0	9	5314
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP272	Blood Clotting Cascade	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP3599	Transcription factor regulation in adipogenesis	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP167	Eicosanoid Synthesis	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP545	Complement Activation	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP357	Fatty Acid Biosynthesis	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP100	Glutathione metabolism	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP3645	NAD+ biosynthetic pathways	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP1584	Type II diabetes mellitus	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP1424	Globo Sphingolipid Metabolism	1.00000000000207	2.06818545025011e-12	22	0	0	9	5314
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	1.00000000000238	2.38430589912911e-12	91	0	0	9	5314
WP3925	Amino Acid metabolism	1.00000000000238	2.38430589912911e-12	91	0	0	9	5314
WP2276	Glial Cell Differentiation	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP2338	miRNA Biogenesis	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP3407	FTO Obesity Variant Mechanism	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP1589	Folate-Alcohol and Cancer Pathway	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP136	Phase I biotransformations, non P450	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP1604	Codeine and Morphine Metabolism	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP3655	Hypothetical Craniofacial Development Pathway	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP2485	NAD Biosynthesis II (from tryptophan)	1.00000000000244	2.44266306939721e-12	8	0	0	9	5314
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	1.00000000000317	3.17013763054476e-12	66	0	0	9	5314
WP2324	AGE/RAGE pathway	1.00000000000317	3.17013763054476e-12	66	0	0	9	5314
WP183	Proteasome Degradation	1.00000000000317	3.17013763054476e-12	66	0	0	9	5314
WP2374	Oncostatin M Signaling Pathway	1.00000000000317	3.17013763054476e-12	66	0	0	9	5314
WP2059	Alzheimers Disease	1.00000000000374	3.74357580923057e-12	148	0	0	9	5314
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP22	IL-9 Signaling Pathway	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP3287	Overview of nanoparticle effects	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP2879	Farnesoid X Receptor  Pathway	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP404	Nucleotide Metabolism	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP1992	TarBasePathway	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP247	Small Ligand GPCRs	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP697	Estrogen metabolism	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP384	Apoptosis Modulation by HSP70	1.00000000000406	4.06308704916663e-12	19	0	0	9	5314
WP474	Endochondral Ossification	1.00000000000622	6.21970672984305e-12	65	0	0	9	5314
WP206	Fatty Acid Omega Oxidation	1.00000000000843	8.42543539189716e-12	15	0	0	9	5314
WP3	Transcriptional activation by NRF2	1.00000000000843	8.42543539189716e-12	15	0	0	9	5314
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000000843	8.42543539189716e-12	15	0	0	9	5314
WP197	Cholesterol Biosynthesis	1.00000000000843	8.42543539189716e-12	15	0	0	9	5314
